‚XŒŽ‚Μ—\’θ•\

—ί˜a‚S”N‚XŒŽ

@
“ϊ•t —j“ϊ j“ϊ –ςάŽt‰οsŽ–—\’θ
1 –Ψ    
2 ‹ΰ    
3 “y    
4 “ϊ    
5 ŒŽ    
6 ‰Ξ   ˜JΠEƒAƒtƒ^[Ώ‹‚ΜŽs–ςŽ––±‹Η’ρoŠϊŒΐ
7 …   ‚­‚Ώ‚©‚ηH‚Χ‚ιŠy‚΅‚έ‚πŽx‰‡‚·‚鋦‹c‰ο–πˆυ‰οi΅έΧ²έ‰ο‹c@‚P‚XF‚R‚O`j
8 –Ψ    
9 ‹ΰ   έ‘ξˆγ—ÁE‰ξŒμ•ΫŒ―ˆΟˆυ‰οiƒIƒ“ƒ‰ƒCƒ“‰ο‹c@‚P‚XF‚R‚O`j
10 “y    
11 “ϊ    
12 ŒŽ   uˆ•ϋ‚Ή‚ρ–‡”vŽ©ŒΘ\Œ§–ς’ρo“ϊi•ΫŒ―–ς‹Η‚̂݁j
Žs–ςΆŠU‹³ˆηiƒAƒ‹ƒJƒX‚r‚`‚r‚d‚a‚n@‚P‚XF‚P‚T`j
13 ‰Ξ    
14 …   ŽO–π‰ο’†Ž~
‚­‚Ώ‚©‚ηH‚Χ‚ιŠy‚΅‚έ‚πŽx‰‡‚·‚鋦‹c‰ομ‹Ζ•”‰οi΅έΧ²έ‰ο‹c@‚P‚XF‚R‚O`j
15 –Ψ   ΓήέΐΩΜͺ½Γ¨Κήي֌W’c‘̍‡“―‹¦‹c‰οi΅έΧ²έ‰ο‹c@‚P‚XF‚O‚O`j
16 ‹ΰ    
17 “y    
18 “ϊ    
19 ŒŽ Œh˜V‚Μ“ϊ  
20 ‰Ξ   ‚³‚Ή‚ΪŒ’N‚Ζ•ŸŽƒƒtƒFƒXƒeƒBƒoƒ‹Šι‰ζŒŸ“’‰ο‹ciŽs–ς‰ο‹cŽΊ@‚P‚XF‚R‚O`j
21 …   ν–±‰οiŽs–ς‰ο‹cŽΊ@‚P‚XF‚R‚O`j
22 –Ψ    
23 ‹ΰ H•ͺ‚Μ“ϊ  
24 “y    
25 “ϊ    
26 ŒŽ    
27 ‰Ξ    
28 …    
29 –Ψ   Žs–ςΆŠU‹³ˆηiƒIƒ“ƒ‰ƒCƒ“Œ€C‰ο@‚P‚XF‚P‚T`j
²’•ΫŽsCKD‹y‚ΡDKD“™‚̑΍τ‚Ι‚¨‚―‚ιˆΣŒ©ŒπŠ·‰οiŽs–πŠ@‚P‚XF‚R‚O`j
30 ‹ΰ    
@

Valid XHTML 1.0

Valid CSS

‚¨–β‚’‡‚ν‚Ή | ƒTƒCƒgƒ}ƒbƒv | ‚²—˜—pˆΔ“ΰ | –ςάŽt‰ο | CopyrightiCj2004 Sasebo Pharmaceutical Association All Rights Reserved.